For example, NPAT has been shown to undergo a truncated deletion in Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and this mutation can serve as a candidate risk factor for Hodgkin lymphoma (53). Here, NPAT is linked to Hodgkins lymphoma.